Valerio Therapeutics Société anonyme

€0.47As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALVIOHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (14.89%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 2.13
PE TTM —
TSR TTM 428.09%
Mkt cap €234.7M
ROIC (25.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.527
12.09%
(73.12%)
Hold 3|10|12|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
34.11%
23.90%
26.10%
27.64%
Revenue€M
16.32
16.78
17.24
18.24
10.93%
11.59%
12.26%
16.39%
Peers (US$263.6M)
Cap (US$)
PE
534.5M
—
230.0M
—
132.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.183
0.222
0.220
EBIT/Intx
0.595
0.146
0.140
Own earn%
131.10
(21.70)
(11.72)
Sh yield%
41.51
28.01
27.42
Owners
Insiders/Inst%
13.53
58.68
Short interest%
1.81
SBC / revenue%
4.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–19
$1 testx
0.1
Incr. ROIC%
2